Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Down 5% – Here’s What Happened

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) were down 5% during trading on Wednesday . The stock traded as low as $9.6017 and last traded at $9.6026. Approximately 6,325 shares traded hands during trading, a decline of 93% from the average daily volume of 96,967 shares. The stock had previously closed at $10.1080.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on SGIOY. The Goldman Sachs Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a research report on Wednesday, April 8th. Zacks Research lowered shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong sell” rating in a research report on Thursday, April 16th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR currently has an average rating of “Reduce”.

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 0.9%

The firm’s 50-day moving average price is $10.98 and its 200-day moving average price is $9.62. The company has a market cap of $16.38 billion, a price-to-earnings ratio of 12.67, a price-to-earnings-growth ratio of 0.75 and a beta of 0.19. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.84 and a quick ratio of 5.21.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings data on Friday, January 30th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.09. The company had revenue of $966.53 million during the quarter, compared to analyst estimates of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.82% and a return on equity of 13.70%. Sell-side analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.73 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.